Esophageal cancer clinical trials are constantly being conducted to test new therapies that have shown promise in preliminary studies. Through clinical trials, patients have access to treatments that aren’t yet available in other settings, and researchers have the opportunity to compare emerging therapies to the currently used options.
Every cancer treatment, even those that are currently considered the “gold standard” for treating esophageal cancer, was once only available through a clinical trial. Today’s trials are focused on exploring new options such as:
- Novel chemotherapy drugs and combinations
- Advanced diagnostic techniques for early-stage cancers
- Innovative therapies such as electrocoagulation, immunotherapy, laser therapy and targeted genetic therapies
At Moffitt Cancer Center, we’re a recognized leader in esophageal cancer research. Moffitt is a National Cancer Institute-designated Comprehensive Cancer Center, and we have earned this designation through our commitment to investigative research. At any given time, we are conducting several different esophageal cancer studies, and we won’t conclude our efforts until there’s a proven cure.
When you come to Moffitt for esophageal cancer treatment, you can feel confident that you’re receiving the most advanced care possible – whether or not you choose to participate in a clinical trial. Our oncologists are extremely involved in the clinical trial process, and they take a bench-to-bedside approach, which means that they draw from their laboratory findings every time they create a patient’s care plan. This helps us give our patients the best possible chances of survival, while improving their overall quality of life.